Produced in BALB/c mouse ascites after inoculation with hybridoma of mouse myeloma cells (NS-1) and spleen cells derived from a BALB/c mouse immunized with E.coli-expressed recombinant human CAR (76-348 aa).
Produced in BALB/c mouse ascites after inoculation with hybridoma of mouse myeloma cells (NS-1) and spleen cells derived from a BALB/c mouse immunized with E.coli-expressed recombinant human SHP (1-257 aa).
Produced in BALB/c mouse ascites after inoculation with hybridoma of mouse myeloma cells (NS-1) and spleen cells derived from a BALB/c mouse immunized with Baculovirusexpressed recombinant RORβ (134-233 aa).
Produced in BALB/c mouse ascites after inoculation with hybridoma of mouse myeloma cells (NS-1) and spleen cells derived from a BALB/c mouse immunized with E.coli-expressed recombinant human PTX3 (18-178 aa).
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human LXRα (164-447 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human ERβ (2-88 aa) and mouse myelomacells (NS-1)
Produced in BALB/c mouse ascites after inoculation with hybridoma of mouse myeloma cells (NS-1) and spleen cells derived from a BALB/c mouse immunized with Baculovirusexpressed recombinant mouse Sall4 (95-216 aa).
Produced in BALB/c mouse ascites after inoculation with hybridoma of mouse myeloma cells (NS-1) and spleen cells derived from a PTX3 KO mouse immunized with recombinant human PTX3 (18-381 aa).
Produced in BALB/c mouse ascites after inoculation with hybridoma of mouse myeloma cells (NS-1) and spleen cells derived from a PTX3 KO mouse immunized with recombinant human PTX3 (18-381 aa).
Produced in BALB/c mouse ascites after inoculation with hybridoma of mouse myeloma cells (NS-1) and spleen cells derived from a PTX3 KO mouse immunized with recombinant human PTX3 (18-381 aa).